Hepatic Cell News Volume 6.17 | May 14 2022

    0
    17






    2022-05-13 | HCN 6.17


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.17 – 13 May, 2022
    TOP STORY

    DNA Hypermethylation Modification Promotes the Development of Hepatocellular Carcinoma by Depressing the Tumor Suppressor Gene ZNF334

    Researchers reported significant differences in the DNA methylation spectrum among the three types of tissues.
    [Cell Death & Disease]

    Full Article

    He needed a better model system. So he invented a new organoid. Watch James Wells' webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Opposing Roles of HDAC6 in Liver Regeneration and Hepatocarcinogenesis

    HDAC6 ablation induced cellular senescence in primary MEFs and inhibited cell proliferation in HepG2 cells and liver regeneration after 2/3 partial hepatectomy.
    [Cancer Science]

    Abstract

    Activated AXL Protects against Hepatic Ischemia-Reperfusion Injury by Upregulating SOCS-1 Expression

    RAXL activation protected the liver from ischemia-reperfusion injury by upregulating SOCS-1 and inhibiting the toll-like receptor 4/myeloid differentiation factor-88/nuclear factor kappa-B signaling axis.
    [Transplantation]

    Full Article

    Modification of Lysine Deacetylation Regulates Curcumol-Induced Necroptosis through Autophagy in Hepatic Stellate Cells

    Scientists indicated that curcumol activated Sirt1 to promote Atg5 deacetylation and enhanced its protein–protein interaction function, thereby inducing autophagy and promoting the necroptosis of hepatic stellate cells to reduce liver fibrosis.
    [Phytotherapy Research]

    Abstract

    Versican Secreted by Cancer-Associated Fibroblasts Is a Poor Prognostic Factor in Hepatocellular Carcinoma

    Researchers identified cancer-associated fibroblasts-specific proteins in HCC and determine whether they could be potential therapeutic targets.
    [Annals of Surgical Oncology]

    Abstract

    The Bromodomain Inhibitor JQ1 Up-Regulates the Long Non-Coding RNA MALAT1 in Cultured Human Hepatic Carcinoma Cells

    Scientists reported that in HepG2 cells, JQ1 significantly reduced various proliferation-related lncRNAs, but up-regulated the known liver tumor marker, MALAT1.
    [Scientific Reports]

    Full Article

    Melatonin Relieves Liver Fibrosis Induced by Txnrd3 Knockdown and Nickel Exposure via IRE1/NF-kB/NLRP3 and PERK/TGF-β1 Axis Activation

    Melatonin exerted its antioxidant effects directly through its ability to clear free radicals and protected the liver from oxidative damage.
    [Life Sciences]

    AbstractGraphical Abstract

    Ochratoxin a Induces Hepatic Fibrosis through TGF-β Receptor I/Smad2/3 Signaling Pathway

    The authors explored whether the TGF-β receptor I/Smad2/3 signaling pathway was related to epithelial–mesenchymal transition-induced hepatic fibrosis.
    [Environmental Toxicology]

    Abstract

    LIM Protein Ajuba Promotes Liver Cell Proliferation through Its Involvement in DNA Replication and DNA Damage Control

    Researchers reported that in the liver, Ajuba expression was increased during regeneration and in tumor cells and tissues.
    [Febs Letters]

    Abstract

    Evaluation of HZX-960, a Novel DCN1-UBC12 Interaction Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis

    Researchers identified that HZX-960 treatment could attenuate TGFβ-induced liver fibrotic responses by reducing the deposition of collagen I and α-SMA, and upregulating cellular NRF2, HO-1 and NQO1 level in two hepatic stellate cell lines.
    [Biochemistry and Cell Biology]

    Abstract

    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    REVIEWS

    Management of Hepatic Encephalopathy Associated with Advanced Liver Disease

    Recent advances in the pathophysiology of hepatic encephalopathy identifying important key players such as interorgan ammonia metabolism and inflammation has set the basis for new therapies.
    [Clinical Drug investigation]

    Full Article

    INDUSTRY AND POLICY NEWS

    Reimbursement Established for Lung and Liver Transplant in the Netherlands Based on Results from Clinical Trials with XVIVO’s Leading Technologies

    Machine perfusion for lungs and livers is being reimbursed in the Dutch healthcare system. The Netherlands has a pronounced evidence-based healthcare system. Therefore, if a treatment option is proven beneficial for patients the government is likely to approve reimbursement.
    [BioSpace]

    Press Release

    FEATURED EVENT

    Modern Phenotypic Drug Discovery – From Chemical Biology to Therapeutics

    May 22 – 25, 2022
    Denver, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – The Research Institute at Nationwide Children’s Hospital

    The Research Institute at Nationwide Children’s Hospital – Columbus, Ohio, United States

    Postdoctoral Scholarship – Medicinal Chemistry

    University of Gothenburg – Gothenburg, Sweden

    Postdoctoral Position – Viral Hepatitis

    National Institute for Health and Medical Research – Strasbourg, France

    Postdoctoral Associate – Obesity Related Liver Cancer

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Fellow – In Vivo Molecular and Cellular Imaging

    Johns Hopkins University – Baltimore, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter